Prevention of Age-Related Macular Degeneration.

Related Articles

Prevention of Age-Related Macular Degeneration.

Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):520-526

Authors: Singh N, Srinivasan S, Muralidharan V, Roy R, V J, Raman R

Abstract
Age-related macular degeneration (AMD) compromises quality of life. However, the available therapeutic options are limited. This has led to the identification of modifiable risk factors to prevent the development or alter the natural course and prognosis of AMD. The identification and modification of risk factors has the potential for greater public health impact on reducing morbidity from AMD. Likewise, identifying the imaging clues and genetic clues could serve as a guide to recognizing the propensity for progression to severe and end stages of the disease. Several attempts, both successful and unsuccessful, have been made for interventions that could delay the progression of AMD. Of these, pharmacological interventions have shown promising results. The Age-Related Eye Disease Study 1 and 2 have shown the beneficial role of antioxidants in a selected group of patients.

PMID: 29204995 [PubMed - indexed for MEDLINE]

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iZVW6A
via IFTTT